Pediatric burn victims' recovery, diabetes, metabolism aided by fenofibrate (Tricor)

San Diego (April 3, 2005) One of the immediate serious results of sudden extreme trauma or stress, including burns and even surgery, is insulin resistance, or diabetes. As a result, healing is delayed, especially in the case of severe burns, and since the body is unable to fully use blood sugar for energy, muscle tissue is broken down as the body scavenges for other possible energy sources.

However, children with severe flame burns of more than 40% body surface area showed "significantly improved whole body glucose uptake -- almost to normal levels -- after a two-week course of treatment with fenofibrate," according to lead researcher, Melanie Green Cree at the University of Texas Medical Branch, Galveston. (The UTMB trauma center last week treated about 20 adult victims, including several with burns from the British Petroleum refinery after an explosion that killed at least 15 workers and injured dozens more.)

Cree said trauma in children "seems to cause problems with fat metabolism, which in turn may cause insulin resistance. This insulin resistance can be ameliorated with 10-14 days of fenofibrate treatment, and it may significantly improve morbidity outcomes, healing rates, and decrease time spent in the intensive care unit."

Going into the experiment, "we felt that the fat metabolism in the children may be deranged by their burns," Cree said. "We hoped that improving fat metabolism with fenofibrate, which is traditionally used to lower plasma triglycerides, would improve the insulin sensitivity. There is conflicting data about the relationship between glucose and fat metabolism. However, acute burn trauma seriously affects both glucose and fat metabolism, and our results show that by increasing cell mitochondrial fat metabolism with fenofibrate (marketed as Tricor by Abbott Laboratories), glucose metabolism can also be improved," Cree reported.

*Paper presentation: "Fenofibrate improves glucose metabolism in pediatric burns pat


Page: 1 2 3 4

Related biology news :

1. Pediatric ritalin use may affect developing brain, new study suggests
2. Pediatric cancer stem cell identified: understanding the origin of ERMS
3. Pediatrics study shows no link between juice and childrens weight
4. Childrens Hospital Boston presents at the 2006 American Academy of Pediatrics National Conference
5. Childrens Hospital Boston presents at the 2006 Pediatric Academic Societies annual meeting
6. VIASYS Healthcare Neonatal Pediatric Fellowship Award
7. Pediatric center to offer novel rehabilitation approach for spinal cord injury
8. Pediatricians lack confidence in managing obesity, and their own weight might be an important factor
9. Pediatric cardiology researchers describe findings in neurologic outcomes, heart devices
10. No sign that ethnic groups genes cause diabetes, international research team says
11. Structure of enzyme offers treatment clues for diabetes, Alzheimers

Post Your Comments:

(Date:9/25/2019)... HOUSTON (PRWEB) , ... September 25, 2019 , ... ... firm, is pleased to announce it ranked No. 3094 on Inc. Magazine’s annual ... Modality Solutions reported three-year revenue growth of 120 percent. Based on this growth, ...
(Date:9/25/2019)... ... , ... Deep Science Ventures (DSV), a new paradigm for applied ... of cancer research. , Deep Science Ventures was founded to create a better method ... from the start, both at the industry and biological level. , Through their ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... of 3D porous titanium spinal implants with the expansion of its proprietary Ti3D® ... more than tripling the number of cervical and lumbar instrumentation sets available for ...
Breaking Biology News(10 mins):
(Date:9/30/2019)... (PRWEB) , ... September 30, 2019 , ... ... materials science newsletter from Rigaku Corporation , is now available online on ... to X-ray based materials science, including X-ray diffraction, fluorescence and imaging, and presents ...
(Date:9/24/2019)... Calif. (PRWEB) , ... September 24, 2019 , ... ... adipose-derived stem cell company, has completed training and site qualification for clinical trial ... process of recruitment and screening of potential clinical trial participants. , Clinical trial ...
(Date:9/17/2019)... ... 2019 , ... Catalent, a global leader in clinical supply ... Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in ... Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s Clinical ...
(Date:9/17/2019)... STATION, N.J. (PRWEB) , ... September 16, 2019 , ... ... clearing reagents and kits that allow for the complete 3D characterization of tissues through ... Visikol has transitioned into an imaging, image analysis and advanced cell culture focused contract ...
Breaking Biology Technology:
Cached News: